Interleukin‐7/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjögren’s Syndrome
- 15 October 2020
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 73 (4) , 631-640
Abstract
Objective: Primary Sjögren’s syndrome (SS) is characterized by a lymphocytic infiltration of salivary glands (SGs) and the presence of an interferon (IFN) signature. SG epithelial cells (SGECs) play an active role in primary SS pathophysiology. We undertook this study to examine the interactions between SGECs and T cells in primary SS and the role of the interleukin‐7 (IL‐7)/IFN axis.Methods: Primary cultured SGECs from control subjects and patients with primary SS were stimulated with poly(I‐C), IFNα, or IFNγ. T cells were sorted from blood and stimulated with IL‐7. CD25 expression was assessed by flow cytometry. SG explants were cultured for 4 days with anti–IL‐7 receptor (IL‐7R) antagonist antibody (OSE‐127), and transcriptomic analysis was performed using the NanoString platform.Results: Serum IL‐7 level was increased in patients with primary SS compared to controls and was associated with B cell biomarkers. IL7R expression was decreased in T cells from patients with primary SS compared to controls. SGECs stimulated with poly(I‐C), IFNα, or IFNγ secreted IL‐7. IL‐7 stimulation increased the activation of T cells, as well as IFNγ secretion. Transcriptomic analysis of SG explants showed a correlation between IL7 and IFN expression. Finally, explants cultured with anti–IL‐7R antibody showed decreased IFN‐stimulated gene expression.Conclusion: These results suggest the presence of an IL‐7/IFNγ amplification loop involving SGECs and T cells in primary SS. IL‐7 was secreted by SGECs stimulated with type I or type II IFN and, in turn, activated T cells that secrete type II IFN. An anti–IL‐7R antibody decreased the IFN signature in T cells in primary SS and could be of therapeutic interest.Keywords
Funding Information
- Fondation pour la Recherche Médicale (DEQ20150934719)
This publication has 34 references indexed in Scilit:
- Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS CohortPLOS ONE, 2013
- Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunityProceedings of the National Academy of Sciences, 2013
- INTERFEROME v2.0: an updated database of annotated interferon-regulated genesNucleic Acids Research, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- The T cell in Sjogren's syndrome: Force majeure, not spectateurJournal of Autoimmunity, 2012
- Increased expression of interleukin‐7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammationArthritis & Rheumatism, 2010
- Interleukin 7 stimulates tumour necrosis factor α and Th1 cytokine production in joints of patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- Establishment of a convenient system for the long‐term culture and study of non‐neoplastic human salivary gland epithelial cellsEuropean Journal of Oral Sciences, 2002
- Enterocyte Expression of Interleukin 7 Induces Development of γδ T Cells and Peyer's PatchesJournal of Experimental Medicine, 2000